In this issue:
Dupilumab for bullous pemphigoid
Acne associated with upadacitinib treatment
Nemolizumab for prurigo nodularis
Peripheral blood eosinophil increases during dupilumab treatment
Guselkumab in psoriasis after anti-IL-17 failure
Pregnancy outcomes in patients receiving ixekizumab
Long-term tralokinumab for moderate-to-severe atopic dermatitis
Biosimilar rituximab in pemphigus
Anti-BDCA2 antibody litifilimab for systemic lupus erythematosus
Please login below to download this issue (PDF)